For research use only. Not for therapeutic Use.
4-(1H-1,2,4-Triazol-1-ylmethyl)benzenamine is a synthetic compound characterized by a benzeneamine structure with a triazole moiety linked via a methylene group. This compound is of interest in medicinal chemistry due to the biological activity associated with triazole derivatives, including antifungal and antibacterial properties. The triazole ring may enhance its interaction with biological targets, making it a potential candidate for drug development. Research into 4-(1H-1,2,4-Triazol-1-ylmethyl)benzenamine focuses on its pharmacological profiles, mechanisms of action, and applications in treating infectious diseases, highlighting its relevance in the search for novel therapeutic agents in the fight against resistant pathogens.
Catalog Number | R007960 |
CAS Number | 119192-10-8 |
Synonyms | 1-(4-Aminobenzyl)-1,2,4-triazole; 1-(4-Aminobenzyl)-1H-1,2,4-triazole; 4-(1H-1,2,4-Triazol-1-ylmethyl)aniline; [4-[([1,2,4]Triazol-1-yl)methyl]phenyl]amine; |
Molecular Formula | C9H10N4 |
Purity | ≥95% |
Storage | -20°C |
IUPAC Name | 4-(1,2,4-triazol-1-ylmethyl)aniline |
InChI | InChI=1S/C9H10N4/c10-9-3-1-8(2-4-9)5-13-7-11-6-12-13/h1-4,6-7H,5,10H2 |
InChIKey | ZGLQVRIVLWGDNA-UHFFFAOYSA-N |
SMILES | C1=CC(=CC=C1CN2C=NC=N2)N |